Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors

Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors

The sinonasal cavities harbor a wide variety of rare cancer types. Histopathological classification can be challenging, especially for poorly differentiated tumors. Despite advances in surgery and radio-chemotherapy, the 5-year survival rate is still very low. Thus, there is an unmet clinical need f...

Full description

Bibliographic Details
Main Authors: Eva Villanueva-Fernández, Mario A. Hermsen, Laura Suárez-Fernández, Blanca Vivanco, Alessandro Franchi, Rocío García-Marín, Virginia N. Cabal, Helena Codina-Martínez, Sara Lucila Lorenzo-Guerra, José L. Llorente, Fernando López
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomedicines
Subjects:
sinonasal cancer
poorly differentiated tumors
CD8+ TILs
PD-L1
MSI
immunotherapy
Online Access:https://www.mdpi.com/2227-9059/10/9/2205

Internet

https://www.mdpi.com/2227-9059/10/9/2205

Similar Items